ADNEXUS Trademark

Trademark Overview


On Monday, February 13, 2012, a trademark application was filed for ADNEXUS with the United States Patent and Trademark Office. The USPTO has given the ADNEXUS trademark a serial number of 85540626. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 5, 2013. This trademark is owned by Adnexus, a Bristol-Myers Squibb R&D Company. The ADNEXUS trademark is filed in the Pharmaceutical Products category with the following description:

Biotechnology and pharmaceutical products, namely, therapeutic proteins for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
adnexus

General Information


Serial Number85540626
Word MarkADNEXUS
Filing DateMonday, February 13, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 5, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 8, 2012

Trademark Statements


Goods and ServicesBiotechnology and pharmaceutical products, namely, therapeutic proteins for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 21, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAdnexus, a Bristol-Myers Squibb R&D Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 02453

Party NameAdnexus, a Bristol-Myers Squibb R&D Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02453

Trademark Events


Event DateEvent Description
Monday, August 5, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 5, 2013ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 12, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, December 29, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 27, 2012EXTENSION 1 GRANTED
Thursday, December 27, 2012EXTENSION 1 FILED
Thursday, December 27, 2012TEAS EXTENSION RECEIVED
Tuesday, July 3, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 8, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 8, 2012PUBLISHED FOR OPPOSITION
Wednesday, April 18, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, March 31, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, March 31, 2012ASSIGNED TO LIE
Tuesday, March 13, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 9, 2012ASSIGNED TO EXAMINER
Tuesday, February 21, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 16, 2012NEW APPLICATION ENTERED IN TRAM